Home Loewenberg College of Nursing About Us Meghan Taylor

Meghan Taylor, MPH, PhD

Assistant Professor

Phone
(901) 424-0725
Email
mbmadows@memphis.edu
Fax
901-678-3860
Office
Community Health Building
Office Hours
Contact for appointment
 
Meghan Taylor

About Meghan Meadows-Taylor

Dr. Meghan Meadows-Taylor is a highly accomplished professional with a strong background in epidemiology and biostatistics. She earned her Bachelors of Science degree in biology from Freed-Hardeman University and holds both an MPH with a combined concentration in Epidemiology and Biostatistics, and a PhD in Epidemiology from the University of Memphis. With a wealth of experience in laboratory, academic, and healthcare settings, Dr. Meadows-Taylor has held significant roles, including Research Scientist for the Multidisciplinary Thoracic Oncology Team at Baptist Memorial Hospital, and Grants Coordinator at the University of Memphis School of Public Health.

Her research primarily focuses on the multidisciplinary management of lung cancer in community-based healthcare systems, aiming to optimize diagnosis and treatment approaches. Dr. Meadows-Taylor's contributions to the field include investigating the impact of guideline-concordant staging and treatment on survival rates, the effectiveness of multidisciplinary care in community-based healthcare systems, and interest in tobacco cessation. Her dissertation work delved into examining racial disparities in quality of care for lung cancer patients in the Mid-South.

Dr. Meadows-Taylor is highly passionate about emphasizing the importance of comprehensive approaches to patient management and continually advocates for evidence-based practices in healthcare.

  • PhD  2020
  • MPH 2017
  • BS    2015

  • Community/Population Health
  • Health Services Research
  • Palliative Care
  • research Methods

  • American Society of Clinical Oncology
  • SNRS
  • Young Professional Advisory Board West Cancer Foundation

  • Memphis Flyer’s 20 under 30 Class of 2023 (2023)
  • Student Academic Achievement Award (2019)
  • 2nd Place poster for the University of Memphis 29th Annual Student Research Forum (2017)

  • Meadows-Taylor MB, Faris NR, Smeltzer MP, Ray MA, Fehnel C, Akinbobola O, Ariganjoye F, Patel A, Pacheco A, Mehrotra A, Fox R. The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer. Chest. 2022.https://doi.org/10.3390/ijerph17041126
  • Smeltzer MP, Ray MA, Faris NR, Meadows-Taylor MB, Rugless F, Berryman C, Jackson B, Fehnel C, Pacheco A, McHugh L, Robbins ET. Prospective Comparative Effectiveness Trial of Multidisciplinary Lung Cancer Care Within a Community-Based Health Care System. JCO Oncology Practice. 2022:OP-21.
  • Osarogiagbon RU, Liao W, Faris NR, Meadows-Taylor M, Fehnel C, Lane J, Williams SC, Patel AA, Akinbobola OA, Pacheco A, Epperson A. Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort. Journal of Clinical Oncology. 2022:JCO-21.
  • Meadows-Taylor M, Ward K, Chen W, Faris NR, Fehnel C, et al. Interest in Cessation Treatment among People who Smoke in a
    Community-Based Multidisciplinary Thoracic Oncology Program. JTO Clinical Research Reports. 2021;2:100-182.
  • Smeltzer MP, Lee Y-S, Faris NR, Fehnel C, Akinbobola O, Meadows-Taylor M, Spencer D, Sales E, Okun S, Giampapa C, Anga A, Pacheco A, Ray M, Osarogiagbon RU. Trends in Accuracy and Comprehensiveness of Pathology Reports for Resected Non-small Cell Lung Cancer (NSCLC) in a High Mortality Area of the United States. Journal of Thoracic Oncology. 2021. doi: https://doi.org/10.1016/j.jtho.2021.06.027.
  • Ray MA, Faris NR, Fehnel C, Derrick A, Smeltzer MP, Meadows-Taylor MB, et al. Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Healthcare System. JTO Clinical Research Reports. 2021;2(8):100203.
  • Smeltzer MP, Faris NR, Fehnel C, Akinbobola O, Saulsberry A, Meadows-Taylor M, Pacheco A, Ray M, Osarogiagbon RU. Impact of a Lymph Node Specimen Collection Kit on the Distribution and Survival Implications of the Proposed Revised Lung Cancer Residual Disease Classification: A Propensity-Matched Analysis. JTO Clinical and Research Reports. 2021;2(4):100161.
  • Osarogiagbon RU, Smeltzer MP, Faris NR, Ray MA, Fehnel C, Ojeabulu P, Akinbobola O, Meadows-Taylor M, McHugh LM, Halal AM, Levy P, Sachdev V, Talton R, Wiggins L, Shu X-O, Shyr Y, Robbins ET, Klesges LM, Outcomes Following Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study. Journal
    of Thoracic Oncology. 2021;16(4):630-642.
  • Ray MA, Fehnel C, Akinbobola O, Faris NR, Taylor M, Pacheco A, Smeltzer MP, Osarogiagbon RU. Comparative Effectiveness of a Lymph Node Collection kit Versus ‘Heightened Awareness’ on Lung Cancer Surgery Quality and Outcomes. Journal of Thoracic Oncology. 2021;16(5):774-783. 
  • Smeltzer MP, Wynes M, Lantuejoul S, Soo R, Ramalingam S, Varella-Garcia M, Taylor M, et al. The International Association for the
    Study of Lung Cancer (IASLC) global survey on molecular testing in lung cancer. Journal of Thoracic Oncology. 2020;15(9):1434-
    1448. 
  • Mathias JG, Nolan VG, Meadows-Taylor M, Robinson LA, Howell KE, Gurney JG, Hankins JS, Wang WC, Estepp JH, Smeltzer MP. A meta-analysis of toxicities related to hydroxycarbamide dosing strategies. eJHaem. 2020 Jul;1(1):235-8.
  • Thomas K, Voros BA, Meadows-Taylor M, et al. Outcomes of Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs). Cancers (Basel). 2020;12(1):206.
  • Minden-Birkenmaier BA, Meadows MB, Cherukuri K, et al. Manuka honey modulates the release profile of a dHL-60 neutrophil model under anti-inflammatory stimulation. Journal of Tissue Viability. Journal of tissue viability. 2020;29(2):91-99. 
  • Minden-Birkenmaier BA, Meadows MB, Cherukuri K, et al. The effect of manuka honey on dHL-60 cytokine, chemokine, and matrix degrading enzyme release under inflammatory conditions. Med One. 2019;4(2):e190005.
  • Smeltzer MP, Faris NR, Ray MA, Fehnel C, Houston-Harris C, Ojeabulu P, Akinbobola O, Lee YS, Meadows M, Signore S, Wiggins L. Survival before and after direct surgical quality feedback in a population-based lung cancer cohort. Annals of Thoracic Surgery. 2019;107(5):1487-1493. 
  • Smeltzer MP, Rugless FE, Jackson BM, Berryman CL, Faris NR, Ray MA, Meadows M, Patel AA, Roark KS, Kedia SK, DeBon MM, Crossley FJ, Oliver G, McHugh LM, Hastings W, Osborne O, Osborne J, Ill T, Ill M, Jones W, Lee HK, Signore RS, Fox RC, Li J, Robbins ET, Ward KD, Klesges LM, Osarogiagbon RU. Pragmatic trial of a multidisciplinary lung cancer care model in a community healthcare
    setting: Study design, implementation evaluation, and baseline clinical results. Translational Lung Cancer Research. 2018;7(1):88- 102.

NA